HGS/GSK On Track To Initiate Lymphostat-B Phase III Study In 2006
This article was originally published in The Pink Sheet Daily
Executive Summary
Full Phase II study results show promise in treatment of lupus even though Lymphostat-B did not meet primary endpoints, the firm says.